Human Antibodies
-
Vanderbilt University School of Medicine Basic Sciences adds Carterra’s LSAXT instrument to speed drug and vaccine research and advance patient care
The Center for Structural Biology in the School of Medicine Basic Sciences will be a hub of research innovation using Carterra’s platform in traditional and AI-driven workflows for characterizing both antibodies and other biomolecules Read MoreSep. 25, 2024
-
Crowe receives national award for COVID antibody research
James Crowe Jr., MD, director of the Vanderbilt Vaccine Center, and Michel Nussenzweig, MD, PhD, of The Rockefeller University, have been jointly awarded the 2022 Harrington Prize for Innovation in Medicine for “groundbreaking work” that enabled the use of human antibodies to treat COVID-19. The announcement was made… Read MoreApr. 1, 2022